| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
1994-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ac21e18a80097a6d710b0c4c5f083ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b6a0184231b75235d6821e60b01456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a485e347b2c847513e1563123995e9ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41a9f73d398300fba76d51ec4dacda47 |
| publicationDate |
1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2173456-A1 |
| titleOfInvention |
Inhibitors of phosphoinositide-specific phospholipase c |
| abstract |
The present invention is directed to novel .alpha.-hydroxy-phosphonate compounds which inhibit mammalian phosphoinositide-specific phospholipase-C. The compounds are potent inflammatory and analgesic agents and may be useful for the treatment of cancer. |
| priorityDate |
1993-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |